English | Español

Biogen
Bree Gonzales | Jun 9, 2021

Biogen gets FDA approval for Alzheimer's treatment: 'the first therapy to target the underlying disease process'
Carrie Bradon | Nov 30, 2017

Biogen names new chief financial officer
Carrie Bradon | Nov 27, 2017

Biogen to present at conference this month
Nicholas Gueguen | Jun 11, 2017

European Commission OKs Spinraza to fight spinal muscular atrophy
Jeff Gantt | Dec 14, 2016

Biogen presents PRIME study data at clinical trials meeting
Amanda Rupp | Sep 16, 2016

New data for Zinbryta support long-term safety profile
Amanda Rupp | Aug 12, 2016

Biogen launches new company dedicated to hemophilia
Amanda Rupp | Jun 23, 2016

McKenzie named new Biogen executive vice president

Trending
+ Pharmaceuticals
Patient Daily | Jul 22, 2025

Deputy VP of Public Affairs of PhRMA: 'It's time for Congress to fix the 340B Drug Pricing Program'
Patient Daily | Jul 24, 2025

Long School of Medicine is largest physician trainer in South Texas
Patient Daily | Jul 25, 2025

Healthcare CEO on 340B reform: ‘It’s the abuse by very large, very profitable, tax-exempt institutions that I think needs to change'
Patient Daily | Jul 25, 2025

Balloon sinuplasty marks 20 years since FDA approval